This bibliography contains selected articles identified in the preliminary literature review conducted by the Institute and covering the biochemistry of glycolysis, possible GMI control points, and the biophysical effects of radiowaves.
Adams S (2001) Imaging fluorescent probes in living cells, tissues and animals. Proc. Intl. Soc. Mag. Reason. Med. 9: 1-1ANZCA 2005. Acute pain management: scientific evidence. 2nd ed. 2005 ANZCA Faculty of Pain Medicine.
AIHW 2004. Cancer in Australia 2001 Cancer Series No. 28 Australian Institute of Health and Welfare / Australasian Association of Cancer Registries
Ardizzoni A, Tiseo M, Boni L, et al. (2006) CISA (cisplatin vs. carboplatin) meta-analysis: an individual patient data meta-analysis comparing cisplatin versus carboplatin-based chemotherapy in first-line treatment of advance non-small cell lung cancer (NSCLC). J Clinical Oncology. 24: -
Atsumi T, Chesney J, Metz C, et al. (2002) High expression of inducible 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase (ipfk-2; pfkfb3) in human cancers. . : -
Ben-Yosef R, Kapp D (1995) Direct clinical comparison of ultrasound and radiative electromagnetic hyperthermia applicators in the same tumours. Int J Hyperthermia. 11: 1-10
Ben-Yosef R, Kapp D (1992) Persistent and/or late complications of combined radiation therapy and hyperthermia. Int J Hyperthermia. 8: 733-745Bennett MP, Lengacher C (2006) Humor and laughter may influence health: II. Complementary therapies and humor in a clinical population. Evid Based Complement Alternat Med June 3(2): 187-190.
Bergh J, Jonsson P, Glimelius B, et al. (2001) A systematic overview of chemotherapy effects in breast cancer. Acta Oncologica. 40: 253-281 Berghmans T, Paesmans M, Meert A, et al. (2006) Survival improvement in resectable non-small cell lung cancer with (neo)adjuvant chemotherapy: results of a meta-analysis of the literature.. Lung Cancer. 51: 261-262
Birim O, Kappetein P, Goorden T, et al. (2005) Proper treatment selection may improve survival in patients with clinical early-stage nonsmall cell lung cancer. Ann Thorac Surg. 80: 1021-1026
Birring S (2004) Adjuvant chemotherapy and survival in completely resected non-small cell lung cancer. Thorax. 59: 341-
Black D, Heynick L (2003) Radiofrequency (RF) effects on blood cells, cardiac, endocrine, and immunological functions. Bioelectomagnetics Supplement . 6: S187-S195
Blackhall F, Shepherd F, Albain K (2005) Improving survival and reducing toxicity with chemotherapy in advanced non-small cell lung cancer: a realistic goal?. Tret Respir Med. 4: 71-84
Block KI, Block P, Gyllenhaal C (2004) The role of optimal healing environments in patients undergoing cancer treatments: clinical research protocol guidelines. J Alt Comp Med Oct 10(1): S-157-S-170.
Bonnet A Mitochondria-K+ channel axis is suppressed in cancer and its normalization promotes apoptosis and inhibits cancer growth, Cancer Cell (2010).
Bonnet S, Archer S et al (2010) A mitochondria-K+ channel axis is suppressed in cancer and its normalization promotes apoptosis and inhibits cancer growth
Bozoky G, Ruby E, Goher I, et al. (2005) The effect of chemo-radiotherapy on the remission and survival in patients with limited stage small cell lung cancer. Orv Hetil. 146: 1433-1438
Brenner H, Arndt V (2005) Long-term survival rates of patients with prostate cancer in the prostate-specific antigen screening era: population-based estimates for the year 2000 by period analysis. J Clinical Oncology. 23: 441-447
Bria E, Gralla R, Raftopoulos H, et al. (2005) Does adjuvant chemotherapy improve survival in non small cell lung cancer (NSCLC)? A pooled-analysis of 6494 patients in 12 studies, examining survival and magnitude of benefit. J Clinical Oncology. 23: -
Brusselmans K, de Schrijver E, Verhoeven G, et al (2005) RNA Interference-mediated silencing of the acetyl-cola-carboxylase-gene induces growth inhibition and apoptosis of prostate cancer cells. Cancer Research. 65: 6719-6725
Burckhardt C, Anderson K (2003) The quality of life scale (QOLS): reliability, validity, and utilization. Health and Quality of Life Outcomes. 1: -
Byrne B, Crawford J, Gay G, et al. (2004) Trends in chemotherapy use and survival for patients with metastatic non-small cell lung cancer. J Clinical Oncology. 22: -
Camilleri-Brennan J, Steele R (2001) Prospective analysis of quality of life and survival following mesorectal excision for rectal cancer. British J Surgery. 88: 1617-
Caraceni A, Brunelli C, Martini C, et al. (2005) Cancer pain assessment in clinical trials. A review of the literature (1999-2002). J Pain and Symptom Management. 29: 507-519
Caraceni A, Cherny N, Fainsinger R, et al. (2002) Pain management tools and methods in clinical research in palliative care: recommendations of an expert working group of the european association of palliative care. J Pain and Symptom Management. 23: 239-255
Cassell (1982) The nature of suffering and the goals of medicine. NEJM 306(11): 639-645
Chan A, Mao A, Wu T, et al. (2005) Meta-analysis comparing carboplatin and cisplatin-based chemotherapy in advanced non-small cell lung cancer. J Clinical Oncology. 23: -
Chan Y, Meng M, Wu K, et al (2005) Experimental study of radiation efficiency from an ingested source inside a human body model. Conference. : -
Chevalier T, Scagliotti G, Natale R, et al. (2005) Efficacy of gemcitabine plus platinum chemotherapy compared with other platinum containing regimens in advanced non-small-cell lung cancer: a meta-analysis of survival outcomes. Lung Cancer. 47: 69-80
Collette L, van Andel G, Bottomley A, et al. (2001) Is baseline quality of life useful for predicting survival with hormone-refractory prostate cancer? A pooled analysis of three studies of the European organisation for research and treatment cancer genitourinary group. J Clinical Oncology. 22: 3877-3885
Cuezva J, Krajewska M, Lopez K, et al. (2002) The bioevergetic signature of cancer; a marker of tumour progression. Cancer Research. 62: 6674-681
D’Addario G, Strasser F, Ribi K, et al. (2006) Quality of life (QoL) in SAKK 19/03: A multicenter phase II study of first-line gefitinib followed by chemotherapy in patients with advanced non-small cell lung cancer (NSCLC). Swiss group for clinical cancer reserch (SAKK).. J Clinical Oncology. 24: -
Dooms C, Pat K, Vansteenkiste J (2006) The effect of chemotherapy on symptom control and quality of life in patients with advanced non-small cell lung cancer. Expert Review of Anticancer Therapy. 6: 531-544
DuBois J, Hay M, Borduret G (1990) Superficial microwave-induced hyperthermia in the treatment of chest wall recurrences in breast cancer. Cancer. 66: 848-852
Erner E (2005) Genome semantics, in silico multicellular systems and the central dogma. FEBS Letters. 579: 1779-1782
Gamaz M, Ameur S, Chaouche D, et al. (2004) A retrospective analysis to evaluate adjuvant chemotherapy after radical surgery on survival and disease recurrence in patients with stage I, II, IIA non-small cell lung cancer (NSCLC). J Clinical Oncology. 22: -
Gandey A (2006) Thermal ablation and radiotherapy boost lung cancer survival. J Vasc Interv Radiol. 17: 0-0
Ganz P, Desmond K, Leedham B, et al. (2002) Quality of life in long-term, disease-free survivors of breast cancer: a follow-up study. J the National Cancer Institute. 94: 39-49
Girgis A, Adams J, Sibbritt D (2005) The use of complementary and alternative therapies by patients with cancer. Oncology Research. 15: 281-289
Gralla R, Thatcher N (2004) Quality-of-life assessment in advanced lung cancer: considerations for evaluation in patients receiving chemotherapy. Lung Cancer. 46: 41-17
Hand J, Machin D, Vernon C, et al. (1997) Analysis of thermal parameters obtained during phase III trials of hyperthermia as an adjunct to radiotherapy in the treatment of breast carcinoma. Int J Hyperthermia. 13: 343-364
Hanigan M, Devarajan P (2003) Cisplatin nephrotoxicity: molecular mechanisms. Cancer Therapy. 1: 47-61
Hashine K, Azuma K, Koizumi T, et al. (2005) Health-related qualit of life and treatment outcomes for men with prostate cancer treated by combined external-beam radiotherapy and hormone therapy. International J Clinical Oncology. 10: 45-50
Hayashi K, Iida T, Iwata M, et al. (1999) Multidisciplinary treatment with and without hyperthermia for ovarian carcinoma. Int J Clin Oncol. 4: 378-383
Herbert A (1981) Natural electrical RF oscillation from cells. J Bioenergetics and Biomembranes. 13: 149-169
Holt J (1986) The fundamental chemistry of life. Medical Hypotheses. 12: 359-367
Holt J (1997) A theoretical biochemical basis of cancer: confirmation by electromagnetic radiation. J Orthomolecular Medicine. 12: 149-163
Holt J (1996) Cancer therapy by immobilizing mitotic energy sources. J Orthomolecular Medicine. 11: 100-110
Holt J (1995) Some characteristics of the glutathione cycle revealed by ionising and non-ionising electromagnetic radiation. Medical Hypotheses. 45: 345-368
Holt J (1993) The glutathione cycle is the creative reaction of life and cancer. Cancer causes oncogenes and not vice versa. Medical Hypotheses. 40: 262-266
Holt J (1988) Microwaves are not hyperthermia. The Radiographer. 35: 151-162
Holt J (1983) Cancer, a disease of defective glucose metabolism. Medical Hypotheses. 10: 133-150
Holt J (2004) The energy system creating life and cancer from inanimate compounds. J Orthomolecular Medicine. 19: 141-161
Holt J (2004) The unique exponential growth of life is powered by anaerobic glycolysis. J Molecular Liquids. 114: 193-206
Holt J (2001) The metabolism of sulphur in relation to the biochemistry of cystine and cysteine: its fundamental importance in biology. A cyclic interchange between their mono- and di-sulphides is the unique reaction creating life and intelligence. Medical Hypotheses. 56: 658-676
Holt J, Nelson A (1985) Combined microwave therapy. The Medical J Australia. 142: 707-
Holt J, Stanford W (1986) The synergism between hyperthermia and ionising radiation. The British J Radiology. 59: 795-796
Holzner B, Kemmler G, Kopp M, et al (2001) Quality of life in breast cancer patients – not enough attention for long-term survivors?. Psychosomatics. 42: 117-123
Hotta K, Matsuo K, Ueoka H, et al. (2004) Role of adjuvant chemotherapy in patients with resected non-small-cell lung cancer: reappraisal with a meta-analysis of randomized controlled trials. J Clinical Oncology. 22: 3860-3867
Joines W, Jirtle R, Rafal D, et al. (1980) Microwave power absorption differences between normal and malignant tissue. Nat J Radiation Oncology Biol Phys. 6: 681-687
Joseph J, Al-Qaisieh B, Ash D, et al. (2004) Prostate-specific antigen relapse-free survival in patients with localized prostate cancer treated by brachytherapy. BJU International. 94: 1235-
Kapp D, Fessenden P, Samulski T, et al. (1988) Stanford University institutional report. Phase I evaluation of equipment for hyperthermia treatment of cancer. Int J Hyperthermia. 4: 75-115
Kekwick R, Pedersen K (Unknown year) CCCVIII Some physico-chemical characteristics of the yellow respiratory enzyme. . : 2201-2205
Kirson E, Gurvich Z, Schneiderman R, et al. (2004) Disruption of cancer cell replication by altering electric fields. Cancer Research. 64: 3288-3295
Kobayashi A, Yamamoto N, Kirschvink J (1997) Studies of inorganic crystals in biological tissue: magnetite in human tumor. J the Japan Society of Powder and Power Metallurgy. 44: 294-300
Koller M, Lorenz W, Wagner K, et al. (2000) Expectations and quality of life of cancer patients undergoing radiotherapy. J R Soc Med. 93: 621-628
Kruger R, Miller K, Reynolds H, et al. (2000) Breast cancer in vivo: contrast enhancement with thermoacousitc Ct at 434 MGz-feasibility study. Radiology. 216: 279-283
Kuhl D (2002) What dying people want. ABC Books
Langendijk J, Aaronson N, ten Velde G, et al. (2000) Pretreatment quality of life of inoperable non-small cell lung cancer patients referred for primary radiotherapy. Taylor & Francis. 39: 949-958
Li R, Wheeler T, Dai H, et al. (2004) High level of androgen receptor is associated with aggressive clinicopathologic features and decreased biochemical recurrence-free survival in prostate: cancer patients treated with radical prostatectomy. American J Surgical Pathology. 28: 928-934
Lindholm C, Andreasson L, Knoos T, et al. (1990) Arterial rupture after microwave-induced hyperthermia and radiotherapy. Int J Hyperthermia. 6: 499-509
Mac Manus M, Matthews J, Wada M, et al. (2006) Unexpected long-term survival after low-dose palliative radiotherapy for nonsmall cell lung cancer. Cancer. 106: 1110-1116
Masunaga S, Hiraoka M, Takahashi M, et al. (1990) Clinical results of thermoradiotherapy for locally advanced and/or recurrent breast cancer – comparison of results with radiotherapy alone. Int J Hyperthermia. 6: 487-197
McCulloch M, See C, Shu X, et al. (2006) Astragalus-based Chinese herbs and platinum-based chemotherapy for advanced non-small-cell lung cancer: meta-analysis of randomized trials. J Clinical Oncology. 24: 419-430
Melzack R (1975) The McGill pain questionnaire; major properties and scoring methods. Pain. 1: 277-299
Memorandum (between John Poynton and David Bonnin). Dr John Holt GBA/UHF and Combined UHF/X-ray Therapies. July 2005.
Michaelson S (1980) Microwave biological effects: an overview. Proceedings of the IEEE. 68: 40-49
National Health and Medical Research Council (NHMRC) (2005). Review of the use of microwave therapy for the treatment of patients with cancer. September, 2005.
National Institute for Occupational Safety and Health (NIOSH) (1987) NIOSH Health Hazard Evaluation Report No. HETA 87-169-1830
Nelson A, Holt J (1978) Combined microwave therapy. The Medical J Australia. : -
Newell S, Sanson-Fisher R (2000) Australian oncologist’s self-reported knowledge and attitudes about non-traditional therapies used by cancer patients. MJA. 172: 110-113
Nordin K, Berglund G, Terje I, et al. (1999) The mental adjustment to cancer scale – a psychometric analysis and the concept of coping. Psycho-oncology. 8: 250-259
Not Known (1976) The Tronado microwave machine: a further report. The Medical J Australia. 31st July: 156-157
Nowak A, Stockler M, Byrne M (2004) Assessing quality of life during chemotherapy for pleural mesothelioma: feasibility, validity, and results of using the European organization for research and treatment of cancer core quality of life questionnaire and lung cancer module. J Clinical Oncology. 22: 3172-3180
O’Brien M, Anderson H, Kaukel E, et al. (2004) SRL172 (killed Mycobacterium vaaccae) in addition to standard chemotherapy improves quality of life without affecting survival, in patients with advanced non-small-cell lung cancer: phase III results. Annals of Oncology. 15: 906-914
Osaro E, H.S.A. Aluyi (2004) Oxygen uptake kinetics of pseudomonas sp. Strain vb grown under limiting concentration of 2-methoxyethanol. African J biotechnology. 2: 353-354
Overgaard J, Gonzalez Gonzalez D, Hulshof M, et al. (1995) Randomised trial of hyperthermia as adjuvant to radiotherapy for recurrent or metastatic malignant melanoma. The Lancet. 345: 540-543
Overgaard J, Gonzalez Gonzalez D, Hulshof M, et al. (1996) Hyperthermia as an adjuvant to radiation therapy of recurrent or metastatic malignant melanoma. A multicentre randomized trial by the European Society for Hyperthermic Oncology. Int J Hyperthermia. 12: 3-20Palsson MB, Norberg A (??) Breast cancer patients’ experiences of nursing care with the focus on emotional support: the implementation of a nursing intervention. J Adv Nurs 21(2): 277-285.
PapandreouI, Krishna Cm Kaper F, et al. (2005) Anoxia is necessary for tumour cell toxicity caused by a low-oxygen environment. Cancer Research. 65: 3171-3178
Paul S, Simons J, Mabjeesh J (2004) HIF at the crossroads between ischemia and carcinogenesis. J Cellular Physiology. 200: 23-30
Perkins G, Slater E, Sanders G, et al. (2003) Serum tumour markers. American Family Physician. 68: 1075-1082
Perumal S, Shanthi P, Sachdanandam P (2005) Energy-modulating vitamins–a new combinatorial therapy prevents cancer cachexia in rat mammary carcinoma. Br J Nutr. 93: 901-909
Pienta K, Smith D (2005) Advances in prostate cancer chemotherapy: a new era begins. CA Cancer J Clin. 55: 300-318Pocock S (1979) Allocation of patients to treatment in clinical trials. Biometrics 35 (March 1979) 183-197.Pocock S (1982) Statistical aspects of clinical trial design. The Statistician 31(1)
Porter C, Kodama K, Gibbons R, et al. (2006) 25-year prostate cancer control and survival outcomes: a 40-year radical prostatectomy single institution series. J Urol. 176: 569-574
Potosky A, Davis W, Hoffman R, et al. (2004) Five-year outcomes after prostateectomy or radiotherapy for prostate cancer: the prostate cancer outcomes study. J the National Cancer Institute. 96: 1358-1367
Ristow M (2006) Oxidative metabolism in cancer growth. Current Opinion in Clinical Nutrition and Metabolic Care. 9: 339-345
Rosser C, Kamat A, Wang X, et al. (2006) Biochemical disease-free survival in men younger than 60 years with prostate cancer treated with radical prostatectomy. Urology. 67: 769-773
RTRI 2006 Radiowave Transmitter Control Software (TXCS) Data Interface Specification authored by Dr Paul Taylor in consultation with Bill Macham (3 July 2006).
Ryan C, Zelefsky M, Heller G, et al. (2004) Five-year outcomes after neoadjuvant chemotherapy and conformal radiotherapy in patients with high-risk localized prostate cancer. Urology. 64:
Sainsbury BMJ 2000;321:745-750
Sandler A (2003) Chemotherapy for small cell lung cancer. Semin Oncol. 30: 9-25
Segelov E (2006) The emperor’s new clothes – can chemotherapy survive? Australian Presceiber. 29: 2-3
Selak M, Armour S, MacKenzie E, et al. (2005) Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-a prolyl dyroxylase. Cancer Cell. 7: 77-85
Senior A, McGowan S, Hilf R (1975) A comparative study on inner membrane enzymes and transport systems in mitochondria from R3230AC mammary tumour and normal rat mammary gland. Cancer Research. 35: 2061-2067
Sharpless N, DePinho A (2002) Good cop/bad cop. Cell. 110: 9-12
Shchepotin I, Evans S, Chorny V, et al. (1994) Intensive peroperative radiotherapy with local hyperthermia for the treatment of gastric carcinoma. Surgical Oncology. 3: 37-44
Silvestris N, Leone B, Numico G, et al. (2005) Present status and perspectives in the treatment of hormone refractory prostate cancer. Oncology . 69: 273-282
Simonnet H, Demont J, Pfeiffer K, et al. (2003) Mitochondial comples I is deficient in renal oncocytomas. Carcinogenesis. 24: 1461-1466
Sloan J (2003) Quality-of-life meta-analysis: why treat it differently?. J Clinical Oncology. 21: 1422-1423
Streckert J (2003) Technical equipment requirements in investigations of radiofrequency effects in biological systems. Forschungsgemeinschaft Funk. 18: 1-19
The Economist (2010) Cramping tumors. January 18th 2010.
Therapeutic Goods Administration (2006) The Australian Clinical Trial Handbook. 8/2006).
The WHOQoL Group (1994a). The development of the World Health Organization Quality of Life Assessment Instrument (the WHOQoL). In J. Orley and W. Kuyken (Eds). Quality of Life Assessment: International Perspectives. Heidleberg: Springer-Verlag.
Threlfall TJ, Thompson JR (2006). Cancer incidence and mortality in Western Australia, 2004. Department of Health, Western Australia, Perth. Statistical series number 77.
Trask P (2004) Quality of life and emotional distress in advanced prostate cancer survivors undergoing chemotherapy. Health and Qualityo f Life Outcomes . 2: -
Trotter J, Edis A, Blackwell J, et al. (1996) Adjuvant VHF therapy in locally recurrent and primary unresectable rectal cancer. Australasian Radiology. 40: 298-305
University Network of Excellence in Nuclear Engineering (UNENE) (2006) Health risks and benefits of radiation. Radiotherapy.
Van der Zee J, Gonzalez D, van Rhoon G, et al. (2000) Comparison of radiotherapy alone with radiotherapy plus hyperthermia in locally advanced pelvic tumours: a prospective, randomised, multicentre trial. The Lancet. 355: 119-1125
Van Vulpen M, De Leeuw J, Van Gellekom P, et al. (2003) A prospective quality of life study in patients with locally advanced prostate cancer, treated with radiotherapy with or without regional or interstitial hyperthermia. Int J Hyperthermia. 19: 402-413 Van Waveren C, Sun Y, Cheung H, et al (2006) Oxidative phosphorylation dysfunction modulates expression of extracellular matrix – remodeling genes and invasion. Carcinogenesis. 27: 409-418
Vulpen M, de Leeuw A, Raaymakers, et al (2004) Radiotherapy and hyperthermia in the treatment of patients with locally advanced prostate cancer: preliminary results. BJU International. 93: 36-
Warburg O (tr 1931) The Metabolism of Tumours. New York: Richard R. Smith.
Warburg O (1956) On the origin of cancer cells. Science 123:309-314.
Warburg O (1966) The prime cause and prevention of cancer, with two prefaces on prevention. Revised lecture presented at the meeting of Nobel-
Laureates on June 30, 1966 at Lindau, Lake Constance, Germany. The Seconds Revised Edition published by Konrad Triltsch, Wurzburg, Germany 1969
W White CA, Macleod U (2002) ABC of psychological medicine. BMJ; 325(??): 377-380.
Willner J, Viktor W, Jachmann M, et al. (2004) Is survival following post-operative radiotherapy in pN1-non-small cell lung cancer reduced? Results of a multivariate analysis. Oncology Reports. 12: 647-653
Winquist E (2006) Chemotherapy for non-hormone refractory prostate cancer. Can J Urol. 13: 67-70
Wissniowski T, Hansler J, Neureiter D, et al. (2003) Activation of tumor-specific t lymphocytes by radio-frequency ablation of the VX2 heptoma in rabbits. Cancer Research. 63: 6496-6500Wu G, Fang Y, Yang S, et al. (2003) Glutathione metabolism and its implications for health. American Society for Nutritional Sciences. 22: 489-492
Yang Z, Wu X, Ou Y, et al. (2004) Effect of TCM combined with chemotherapy on immune function and quality of life of patients with non-small cell lung cancer in stage III-IV. Chinese J Integrative Medicine. 10: 181-186
Zeng F, Zimmerman S (1997) Dendrimers in supramolecular chemistry: from molecular recognition to self-assembly. Chem Rev. 97: 1681-1712
Zhu Z, Jiang W, McGinley J, et al. (2005) 2-deoxyglucose as an energy restriction mimetic agent: effects on mammary carcinogenesis and on mammary tumor cell growth in vitro. Cancer Research. 65: 7023-7030